Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?
about
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the EvidenceCannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia PharmacotherapyDopamine D1-like receptor signalling in the hippocampus and amygdala modulates the acquisition of contextual fear conditioningEffects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strainExperimental sleep deprivation as a tool to test memory deficits in rodents.Hyperactivity, startle reactivity and cell-proliferation deficits are resistant to chronic lithium treatment in adult Nr2e1(frc/frc) miceChronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials.Microinjection of valproic acid into the ventrolateral orbital cortex enhances stress-related memory formationSet shifting in a rodent model of attention-deficit/hyperactivity disorder.Instrumental conditioning for food reinforcement in the spontaneously hypertensive rat model of attention deficit hyperactivity disorder.Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder.Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers.Persistent cognitive and morphological alterations induced by repeated exposure of adolescent rats to the abused inhalant toluene.The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats.Peculiarities of latent inhibition formation in SHR rats in conditioned task of different complexity.Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
P2860
Q28075499-706D4F83-A877-45B3-AD1C-5E8376901062Q28078534-F2DCBA2A-5D83-4F9A-B0ED-7C884BBA216BQ30407614-5D85723B-3D61-4238-8386-36E206877149Q30442731-8066C93F-6F82-4262-8A21-3D488854671DQ30445307-CB8442D0-66DC-4390-9A02-E3B550C30AC6Q30469863-7DD2391C-9257-412B-8E3D-3FA57F281175Q30480287-846C52DE-8642-43BF-B5DA-DDA098C5B020Q34542172-02D7B1C4-4017-4E68-9325-7FF5F1C0A204Q42735324-759005A6-41DC-4E7F-97EF-F68F34105752Q43504575-93606342-0E12-44A4-A321-623A7E36CD52Q46890815-4961F8D5-395A-4B19-82CF-3B30EB584146Q48072699-ADB4AF15-0944-4201-8BDE-B9998329725FQ48190211-43225B98-3687-42E9-A01E-09ACDA9B7240Q50760353-4AEA5459-8CE4-454E-BC63-D385A5325BFDQ50795072-E5F2771D-C113-4FA1-9556-E876E26B57F8Q58727916-554A95FA-0039-4FE5-AC45-F326820CDBAB
P2860
Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuroleptic drugs revert the c ...... t processing in schizophrenia?
@en
Neuroleptic drugs revert the c ...... t processing in schizophrenia?
@nl
type
label
Neuroleptic drugs revert the c ...... t processing in schizophrenia?
@en
Neuroleptic drugs revert the c ...... t processing in schizophrenia?
@nl
prefLabel
Neuroleptic drugs revert the c ...... t processing in schizophrenia?
@en
Neuroleptic drugs revert the c ...... t processing in schizophrenia?
@nl
P2093
P2860
P50
P356
P1476
Neuroleptic drugs revert the c ...... t processing in schizophrenia?
@en
P2093
Mariana Bendlin Calzavara
Raquel Levin
Regina Helena Silva
Roberto Frussa-Filho
Sonia Regina Kameda
Vanessa Costhek Abílio
Wladimir Agostini Medrano
P2860
P304
P356
10.1093/SCHBUL/SBN006
P407
P577
2008-02-16T00:00:00Z